Skip to main content

Advertisement

SpringerLink
Log in

Plasma adropin level in patients with pseudoexfoliation

  • Original Paper
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

The aim of this study was to evaluate plasma adropin levels in patients with pseudoexfoliation (PEX). This retrospective case–control study included 35 patients with PEX and 35 individuals without PEX who served as controls. Plasma adropin levels with triglycerides, total cholesterol, low-density lipoprotein (LDL), high-density lipoprotein (HDL), and haemoglobin A1c (HGBA1C) concentrations were measured in both groups. The mean serum adropin levels were 3.24 ± 0.95 ng/mL (range, 1.90–7.88 ng/mL) in patients with PEX syndrome and 5.78 ± 2.85 ng/mL (range, 2.08–5.41 ng/mL) in PEX glaucoma patients. There was no statistically significant difference in mean adropin levels between PEX syndrome and PEX glaucoma patients. However, similar adropin levels were found in the PEX glaucoma patients and the control group (P > 0.05). The mean serum adropin levels were 3.34 ± 0.89 ng/mL (range, 1.90–5.39 ng/mL) in the PEX group and 5.78 ± 2.85 ng/mL (range, 3.08–11.06 ng/mL) in the control group. The mean serum adropin level of the PEX group was significantly lower than that of the control group (P < 0.001). There were no significant differences between the two groups in terms of serum glucose, total cholesterol, LDL, HDL, HGBA1C, triglycerides levels, or body mass index (all P > 0.05). Adropin level is lower in patients with PEX.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ritch R, Schlotzer-Schrehardt U (2001) Exfoliation syndrome. Surv Ophthalmol 45:265–315

    Article  CAS  PubMed  Google Scholar 

  2. Hewitt AW, Sharma S, Burdon KP, Wang JJ, Baird PN, Dimasi DP et al (2008) Ancestral LOXL1 variants are associated with pseudoexfoliation in Caucasian Australians but with markedly lower penetrance than in Nordic people. Hum Mol Genet 17:710–716

    Article  CAS  PubMed  Google Scholar 

  3. Amari F, Umihira J, Nohara M et al (1997) Electron microscopic immunohistochemistry of ocular and extraocular pseudoexfoliative material. Exp Eye Res 65:51–56

    Article  CAS  PubMed  Google Scholar 

  4. Schlötzer- Schrehardt UM, Koca MR, Naumann GO, Volkholz H (1992) Pseudoexfoliation syndrome ocular manifestation of a systemic disorder? Arch Ophthalmol 110(12):1752–1756

    Article  PubMed  Google Scholar 

  5. Mitchell P, Wang JJ, Smith W (1997) Association of pseudoexfoliation syndrome with increased vascular risk. Am J Ophthalmol 124:685–687

    Article  CAS  PubMed  Google Scholar 

  6. Shrum KR, Hattenhauer MG, Hodge D (2000) Cardiovascular and cerebrovascular mortality associated with ocular pseudoexfoliation. Am J Ophthalmol 129:83–86

    Article  CAS  PubMed  Google Scholar 

  7. Naji M, Naji F, Suran D, Gracner T, Kanic V, Pahor D (2008) Systemic endothelial dysfunction in patients with pseudoexfoliation syndrome. Klin Monbl Augenheilkd 225(11):963–967

    Article  CAS  PubMed  Google Scholar 

  8. Kumar KG, Trevaskis JL, Lam DD et al (2008) Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism. Cell Metab 8:468–481

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Lovren F, Pan Y, Quan A et al (2010) Adropin is a novel regulator of endothelial function. Circulation 122:185–192

    Article  Google Scholar 

  10. Lian W, Gu X, Qin Y, Zheng X (2011) Elevated plasma levels of adropin in heart failure patients. Intern Med 50(15):1523–1527

    Article  CAS  PubMed  Google Scholar 

  11. Celik A, Balin M, Kobat MA et al (2013) Deficiency of a new protein associated with cardiac syndrome X; called adropin. Cardiovasc Ther 31(3):174–178

    Article  CAS  PubMed  Google Scholar 

  12. Aydin S (2015) A short history, principles, and types of ELISA, and our laboratory experience with peptide/protein analyses using ELISA. Peptides 72:4–15

    Article  CAS  PubMed  Google Scholar 

  13. Praveen MR, Shah SK, Vasavada AR et al (2011) Pseudoexfoliation as a risk factor for peripheral vascular disease: a case-control study. Eye 25:174–179

    Article  CAS  PubMed  Google Scholar 

  14. Schlötzer-Schrehardt U, Naumann GO (2006) Ocular and systemic pseudoexfoliation syndrome. Am J Ophthalmol 141(5):921–937

    Article  PubMed  Google Scholar 

  15. Ovodenko B, Rostagno A, Neubert TA et al (2007) Proteomic analysis of exfoliation deposits. Invest Ophthalmol Vis Sci 48:1447–1457

    Article  PubMed  Google Scholar 

  16. Streenten BW, Li ZY, Wallace RN, Eagle RC Jr, Keshgegian AA (1992) Pseudoexfoliative fibrillopathy in visceral organs of a patient with pseudoexfoliation syndrome. Arch Ophthalmol 110:1757–1762

    Article  Google Scholar 

  17. Mitchell P, Wang JJ, Smith W (1997) Association of pseudoexfoliation syndrome with increased vascular risk. Am J Ophthalmol 124:685–687

    Article  CAS  PubMed  Google Scholar 

  18. Shrum KR, Hattenhauer MG, Hodge D (2000) Cardiovascular and cerebro-vascular mortality associated with ocular pseudoexfoliation. Am J Ophthalmol 129:83–86

    Article  CAS  PubMed  Google Scholar 

  19. Atalar PT, Atalar E, Kilic H et al (2006) Impaired systemic endothelial function in patients with pseudoexfoliation syndrome. Int Heart J 47:77–84

    Article  PubMed  Google Scholar 

  20. Citirik M, Acaroglu G, Batman C, Yildiran L, Zilelioglu O (2007) A possible link between the pseudoexfoliation syndrome and coronary artery disease. Eye 21:11–15

    Article  CAS  PubMed  Google Scholar 

  21. French DD, Margo CE, Harman LE (2012) Ocular pseudoexfoliation and cardiovascular disease: a national cross-section comparison study. N Am J Med Sci 4:468–473

    Article  PubMed  PubMed Central  Google Scholar 

  22. Tosun M, Simavli H, Önder HI, Erdurmus M (2014) Serum levels of omentin in pseudoexfoliation syndrome. J Glaucoma. doi:10.1097/IJG.0000000000000139

    Google Scholar 

  23. Türkyılmaz K, Öner V, Kırbas A, Sevim MS, Sekeryapan B, Özgür G, Durmus M (2013) Serum ykl-40 levels as a novel marker of inflammation and endothelial dysfunction in patients with pseudoexfoliation syndrome. Eye 27(7):854–859

    Article  PubMed  PubMed Central  Google Scholar 

  24. Zhou JY, Chan L, Zhou SW (2014) Omentin: linking metabolic syndrome and cardiovascular disease. Curr Vasc Pharmacol 12:136–143

    Article  CAS  PubMed  Google Scholar 

  25. Topuz M, Celik A, Aslantas T, Demir AK, Aydin S, Aydin S (2013) Plasma adropin levels predict endothelial dysfunction like flow-mediated dilatation in patients with type 2 diabetes mellitus. J Investig Med 61(8):1161–1164

    Article  CAS  PubMed  Google Scholar 

  26. Kumar KG, Trevaskis JL, Lam DD et al (2008) Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism. Cell Metab 8:468–481

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Celik A, Balin M, Kobat MA et al (2013) Deficiency of a new protein associated with cardiac syndrome X; called adropin. Cardiovasc Ther 31(3):174–178

    Article  CAS  PubMed  Google Scholar 

  28. Zhang C, Zhao L, Xu W, Li J, Wang B, Gu X, Chen J (2014) Correlation of serum adropin level with coronary artery disease. Zhonghua Yi Xue Za Zhi 94:1255–1257

    CAS  PubMed  Google Scholar 

Download references

Funding

No funding supported this study.

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Kırıkkale University Medical Faculty, Kırıkkale University Campus, Ankara Road 6. Km, Yahsihan, 71100, Kirikkale, Turkey

    Tevfik Oğurel, Reyhan Oğurel, Nurgül Örnek & Kemal Örnek

  2. Department of Cardiology, Adana Education and Research Hospital, 01100, Adana, Turkey

    Mustafa Topuz

Authors
  1. Tevfik Oğurel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Reyhan Oğurel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mustafa Topuz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nurgül Örnek
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kemal Örnek
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tevfik Oğurel.

Ethics declarations

Conflicts of interest

None declared.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Oğurel, T., Oğurel, R., Topuz, M. et al. Plasma adropin level in patients with pseudoexfoliation. Int Ophthalmol 36, 737–742 (2016). https://doi.org/10.1007/s10792-016-0185-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-016-0185-8

Keywords

Search

Navigation